What is Cellectar Biosciences INC NEW's Market Cap?

Cellectar Biosciences INC NEW's Market Cap is $22.8M, based on as-reported figures from SEC (XBRL) filings.

What is Cellectar Biosciences INC NEW's Enterprise Value?

Cellectar Biosciences INC NEW's Enterprise Value is -$11.2M, based on as-reported figures from SEC (XBRL) filings.

What is Cellectar Biosciences INC NEW's EV / EBITDA?

Cellectar Biosciences INC NEW's EV / EBITDA is 0.5×, based on as-reported figures from SEC (XBRL) filings.

What is Cellectar Biosciences INC NEW's Net Income (TTM)?

Cellectar Biosciences INC NEW's Net Income (TTM) is -$22.3M, based on as-reported figures from SEC (XBRL) filings.

What is Cellectar Biosciences INC NEW's EBITDA?

Cellectar Biosciences INC NEW's EBITDA is -$23.3M, based on as-reported figures from SEC (XBRL) filings.

What is Cellectar Biosciences INC NEW's Diluted EPS (TTM)?

Cellectar Biosciences INC NEW's Diluted EPS (TTM) is -2.36, based on as-reported figures from SEC (XBRL) filings.

What is Cellectar Biosciences INC NEW's Net Debt?

Cellectar Biosciences INC NEW's Net Debt is -$34.0M, based on as-reported figures from SEC (XBRL) filings.

Cellectar Biosciences INC NEW (CLRB) Financial Statements

Cellectar Biosciences INC NEW

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SNWCK2

XNAS · usd

2.41▲ 0.04 (1.69%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close2.37

Day's Range2.38 – 2.47

52-Week Range2.20 – 6.52

Volume27.6K

Avg Volume37.1K

Share Statistics

Shares Outstanding

Employees11

ExchangeXNAS

Listed2005-04-19

Share count as of August 11, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Cellectar Biosciences INC NEW (CLRB)

What is Cellectar Biosciences INC NEW's Market Cap?: Cellectar Biosciences INC NEW's Market Cap is $22.8M, based on as-reported figures from SEC (XBRL) filings.
What is Cellectar Biosciences INC NEW's Enterprise Value?: Cellectar Biosciences INC NEW's Enterprise Value is -$11.2M, based on as-reported figures from SEC (XBRL) filings.
What is Cellectar Biosciences INC NEW's EV / EBITDA?: Cellectar Biosciences INC NEW's EV / EBITDA is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is Cellectar Biosciences INC NEW's Net Income (TTM)?: Cellectar Biosciences INC NEW's Net Income (TTM) is -$22.3M, based on as-reported figures from SEC (XBRL) filings.
What is Cellectar Biosciences INC NEW's EBITDA?: Cellectar Biosciences INC NEW's EBITDA is -$23.3M, based on as-reported figures from SEC (XBRL) filings.
What is Cellectar Biosciences INC NEW's Diluted EPS (TTM)?: Cellectar Biosciences INC NEW's Diluted EPS (TTM) is -2.36, based on as-reported figures from SEC (XBRL) filings.
What is Cellectar Biosciences INC NEW's Net Debt?: Cellectar Biosciences INC NEW's Net Debt is -$34.0M, based on as-reported figures from SEC (XBRL) filings.